Use of a recombinant deacetylase to convert A1 red blood cells to the acquired B phenotype for quality control purposes

Use of a recombinant deacetylase to convert A₁ red blood cells to the acquired B phenotype for quality control purposes

Blood Transfus. 2024 Mar;22(2):106-110. doi: 10.2450/BloodTransfus.584. Epub 2023 Sep 20.

Jennifer Ricci Hagman^{1

2}, Peter Rahfeld^{3

4}, Stephen G Withers⁴, Jayachandran N Kizhakkedathu⁵, Martin L Olsson^{1

2}, Jill R Storry^{1

2}

¹ Division of Hematology and Transfusion Medicine, Department for Laboratory Medicine, Biomedical Center C14, Lund University, Lund, Sweden.
² Department of Clinical Immunology and Transfusion Medicine, Office for Medical Services, Region Skåne, Lund, Sweden.
³ Avivo Biomedical Inc., Vancouver, BC, Canada.
⁴ Department of Chemistry, University of British Columbia, Vancouver, BC, Canada.
⁵ Department of Pathology and Laboratory Medicine, Centre for Blood Research, Life Sciences Institute, University of British Columbia, Vancouver, BC, Canada.

No abstract available